HEALTH CARE COST IN PATIENTS UNDERGOING ELECTRICAL CARDIOVERSION: AN ANALYSIS FROM THE EDOXABAN VERSUS WARFARIN IN SUBJECTS UNDERGOING CARDIOVERSION OF ATRIAL FIBRILLATION (ENSURE-AF) STUDY

被引：0
|
作者：
Barrrios, Rodriguez J. [1 ]
Goette, A. [2 ]
Kwong, J. [3 ]
Ezekowitz, M. D. [4 ]
Banach, M. S. [5 ]
Hjortshen, S. P. [6 ]
Zamcnyakhin, D. [7 ]
Lip, G. [8 ]
机构：
[1] Daiichi Sankyo Europe GmbH, Munich, Germany
[2] St Vincenz Hosp, Paderborn, GA, Germany
[3] Daiichi Sankyo, Parsippany, NJ USA
[4] Sydney Kimmel Jefferson Univ, Philadelphia, PA USA
[5] Med Univ Lodz, Lodz, Poland
[6] Aalborg Univ Hosp, Aalborg, Denmark
[7] Daiichi Sankyo Dev Ltd, Gerrards Cross, England
[8] Univ Birmingham, Birmingham, W Midlands, England
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 09期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCV44
引用
收藏
页码：A608 / A608
页数：1
相关论文
共 50 条
  • [1] A prospective evaluation of edoxaban compared to warfarin in subjects undergoing cardioversion of atrial fibrillation: The EdoxabaN vs. warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE-AF) study
    Lip, Gregory Y. H.
    Merino, Jose
    Ezekowitz, Michael
    Ellenbogen, Kenneth
    Zamoryakhin, Dmitry
    Lanz, Hans
    Jin, James
    Al-Saadi, Naab
    Mercuri, Michele
    Goette, Andreas
    [J]. AMERICAN HEART JOURNAL, 2015, 169 (05) : 597 - U28
  • [2] Relation of Stroke and Bleeding Risk Profiles to Efficacy and Safety of Edoxaban for Cardioversion of Atrial Fibrillation (from the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation [ENSURE-AF] Study)
    Lip, Gregory Y. H.
    Merino, Jose L.
    Dan, G. Andrei
    Themistoclakis, Sakis
    Ellenbogen, Kenneth A.
    De Caterina, Raffaele
    Goudev, Assen
    Jin, James
    Melino, Michael
    Winters, Shannon M.
    Goette, Andreas
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2018, 121 (02): : 193 - 198
  • [3] Spontaneous conversion in patients with non-valvular atrial fibrillation planned for electrical cardioversion: A subanalysis of the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion Of Atrial Fibrillation (ENSURE-AF) trial
    Cohen, Ariel A.
    Heidbuchel, Hein
    Le Heuzey, Jean-Yves
    De Caterina, Raffaele
    Merino, Jose L.
    Jin, James
    Winters, Shannon M.
    Goette, Andreas
    Lip, Gregory Y. H.
    [J]. AMERICAN HEART JOURNAL, 2019, 209 : 131 - 135
  • [4] Clinical factors related to successful or unsuccessful cardioversion in the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE-AF) randomized trial
    Lip, Gregory Y. H.
    Merino, Jose L.
    Banach, Maciej
    Al-Saady, Naab
    Jin, James
    Melino, Michael
    Winters, Shannon M.
    Koziel, Monika
    Goette, Andreas
    [J]. JOURNAL OF ARRHYTHMIA, 2020, 36 (03) : 430 - 438
  • [5] EDOXABAN THERAPY INCREASES TREATMENT SATISFACTION AND REDUCES UTILIZATION OF HEALTH CARE RESOURCES: AN ANALYSIS FROM THE EDOXABAN VERSUS WARFARIN IN SUBJECTS UNDERGOING CARDIOVERSION OF ATRIAL FIBRILLATION (ENSURE-AF) STUDY
    Goette, Andreas
    Kwong, Winghan
    Ezekowitz, Michael
    Banach, Maciej
    Hjortshoj, Soren
    Zamoryakhin, Dmitry
    Lip, Gregory
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 454 - 454
  • [6] The relationship of renal function to outcome: a post hoc analysis from the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion Of Atrial Fibrillation (ENSURE-AF) study
    Lip, G. Y. H.
    Al-Saady, N.
    Ezekowitz, M. D.
    Banach, M.
    Goette, A.
    [J]. EUROPEAN HEART JOURNAL, 2017, 38 : 1369 - 1369
  • [7] The relationship of renal function to outcome: A post hoc analysis from the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE-AF) study
    Lip, Gregory Y. H.
    Al-Saady, Naab
    Ezekowitz, Michael D.
    Banach, Maciej
    Goette, Andreas
    [J]. AMERICAN HEART JOURNAL, 2017, 193 : 16 - 22
  • [8] Edoxaban versus warfarin in vitamin K antagonist experienced and naive patients from the edoxaban versus warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF) randomised trial
    Koziel, Monika
    Al-Saady, Naab
    Hjortshoj, Soren P.
    Goudev, Assen
    Huber, Kurt
    Cohen, Ariel
    Jin, James
    Melino, Michael
    Winters, Shannon M.
    Goette, Andreas
    Lip, Gregory Y. H.
    [J]. CLINICAL RESEARCH IN CARDIOLOGY, 2020, 109 (08) : 1018 - 1024
  • [9] Edoxaban vs warfarin in vitamin K antagonist experienced and naive patients from the edoxaban versus warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF) randomized trial
    Lip, G. Y. H.
    Al-Saady, N.
    Hjortshoj, S. P.
    Goudev, A.
    Huber, K.
    Cohen, A. -A.
    Jin, J.
    Merino, M.
    Winters, S. M.
    Goette, A.
    [J]. EUROPEAN HEART JOURNAL, 2018, 39 : 414 - 414
  • [10] Edoxaban versus warfarin in vitamin K antagonist experienced and naïve patients from the edoxaban versus warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF) randomised trial
    Monika Kozieł
    Naab Al-Saady
    Søren P. Hjortshøj
    Assen Goudev
    Kurt Huber
    Ariel Cohen
    James Jin
    Michael Melino
    Shannon M. Winters
    Andreas Goette
    Gregory Y. H. Lip
    [J]. Clinical Research in Cardiology, 2020, 109 : 1018 - 1024
12345